Research Progress in the Adjuvant Treatment of non-small Cell Lung Cancer with Chinese Medicine Injections

Non-small cell lung cancer (NSCLC) is a common type of lung cancer. Patients with advanced NSCLC often lose the chance of surgery. Integrated traditional Chinese and western medicine therapy, especially traditional Chinese medicine injection, has shown its advantages in the treatment of non-small cell lung cancer. It plays an anti-cancer role by inhibiting cell proliferation, promoting apoptosis, inhibiting tumor invasion and metastasis, and improving anti-tumor drug resistance. It has shown advantages in reducing adverse reactions, improving efficacy and quality of life of patients.